Transformation Health provides a subscription‑based, telehealth weight‑loss program that prescribes compounded GLP‑1 (semaglutide) or dual GLP‑1/GIP (tirzepatide) medications delivered directly to patients’ homes. The service includes licensed provider oversight, integrated laboratory monitoring, and 24/7 nutrition and side‑effect coaching through a secure platform, all bundled in a single monthly fee without insurance requirements.
Funding
Funding not disclosed
Founders
Product
Problem
Many adults attempting weight loss encounter metabolic adaptation, hormonal shifts, and heightened appetite signaling that undermine calorie‑restriction efforts. Traditional programs often lack prescription‑grade pharmacotherapy, require in‑person visits, and involve complex insurance navigation.
Solution
Transformation Health delivers a subscription‑based, medically supervised weight‑loss program that combines compounded GLP‑1 (semaglutide) or dual GLP‑1/GIP (tirzepatide) medications with personalized coaching and laboratory monitoring. Prospective users complete a brief online health assessment, after which a U.S.-licensed provider reviews the data and issues a tailored prescription. The compounded formulation—available as injectable or oral—ships directly from a state‑licensed pharmacy to the patient’s door. A secure telehealth portal enables continuous provider oversight, dose adjustments, and integration of lab results to ensure safety and efficacy. Certified medical assistants provide ongoing nutrition, lifestyle, and side‑effect counseling through 24/7 messaging. All services are bundled into a single monthly fee, with no insurance required and the ability to cancel at any time.
Target Audience
The primary customers are adults with a BMI of 27 or higher (or ≥25 with a qualifying health condition) who seek prescription‑grade weight‑loss therapy combined with remote clinical support. The service also appeals to individuals preferring a fully virtual care experience that integrates medication, coaching, and lab monitoring.
Features
- Compounded GLP‑1 (semaglutide) and dual GLP‑1/GIP (tirzepatide) formulations, customizable by dose and route (injectable or oral).
- Licensed U.S. providers conduct full clinical review, prescribe, and adjust therapy via a HIPAA‑compliant telehealth platform.
- Integrated laboratory ordering and results dashboard for real‑time monitoring of metabolic markers and medication safety.
- Dedicated care coaching by certified medical assistants delivering nutrition, exercise, and side‑effect management through 24/7 secure messaging.
- Automated fulfillment from FDA‑compliant, state‑licensed compounding pharmacies with discreet home delivery and free shipping.
- All‑inclusive monthly subscription covering medication, provider care, labs, coaching, and shipping; no insurance needed.
- Role‑based access controls and end‑to‑end encryption protect patient data across the platform.